Chronic inflammation and cancer: Potential role of Bcl-2 gene family members as regulators of cellular antioxidant status

Medical Hypotheses

Volumn 52, Issue 1, 1999, Pages 27-30

  Frommel, T O ^a,b   Zarling, E J ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; MUTAGENIC AGENT; PROTEIN BCL 2;

ANTIOXIDANT ACTIVITY; CANCER; CANCER RISK; CELL PROTECTION; CELL SURVIVAL; CHRONIC INFLAMMATION; DIGESTIVE SYSTEM CANCER; MULTIGENE FAMILY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SHORT SURVEY;

EID: 0033023603     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.1997.0621     Document Type: Article

References (29)

1. Simmonds N. J., Rampton D. S. Inflammatory bowel disease - A radical view. Gut 1993; 34: 865-868.
2. Buckley G. B. The role of oxygen free radicals in human disease processes. Surgery 1983; 94: 407-411.
3. Halliwell B., Aruoma O. DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS Letts 1991; 281: 9-19.
4. Schraufstatter I. U., Jackson J. Early injury of cells by external oxidants and the consequences of DNA damage. Cell Mol Mech Inflam 1992; 4: 21-41.
5. Beasley R. P. Hepatitis B virus: The major etiology of hepatocellular carcinoma. Cancer 1988; 61: 1942-1956.
6. Saito I., Miyamura T., Ohbayashi A. et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87: 6547-6549.
7. Ekbom A., Helmick C., Zack M., Adami H-O. Ulcerative colitis and colorectal cancer. A population based study. N Engl J Med 1990; 323: 1228-1233.
8. Cameron A. J., Ott B. J., Payne W. S. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985; 313: 857-859.
9. Parsonnet J., Hansen S., Rodriguez L. et al. Heliobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330: 1267-1271.
10. Lowenfels A. B., Maisonneuve P., DiMagno E. P. et al. Hereditary pancreatitis and the risk of pancreatic cancer. J Natl Cancer Inst 1997; 89: 442-446.
11. Bansal P., Sonnenberg A. Pancreatitis is a risk factor for pancreatic cancer. Pancreas 1995; 109: 247-251.
12. Rashid A., Hamilton S. R. Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine. Gastroenterology 1997; 113: 127-135.
13. Reed J. C. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994; 124: 1-6.
14. Thompson C. B. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-1462.
15. Oltvai Z., Milliman C., Korsmeyer S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-619.
16. Krajewski S., Krajewska M., Shabaik A., Miyashita T., Wang H. G., Reed J. C. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 1994; 145: 1323-1336.
17. Reed J. C., Cuddy M., Haldar S. et al. BCL2-mediated tumorigenicity of a human T-lymphoid cell line: Synergy with MYC and inhibition by BCL2 antisense. Proc Natl Acad Sci USA 1990; 87: 3660-3664.
18. Kitada S., Miyashita T., Tanaka S., Reed J. C. Investigations of antisense oligonucleotides targeted against bcl-2-RNAs. Antisense Res Dev 1993; 3: 157-169.
19. Cotter F. E., Johnson P., Hall P. et al. Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-mouse model. Oncogene 1994; 9: 3049-3055.
20. Sentman C. L, Shutter J. R., Hockenbery D., Kanagawa O., Korsmeyer S. J. Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 1991; 67: 879-888.
21. Strasser A., Harris A., Cory S. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 1991; 67: 889-899.
22. Hockenbery D.M., Oltvai Z. N., Yin X M., Milliman C. L., Korsmeyer S. J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75: 241-251.
23. Kane D. J., Sarafian T. A., Anton R. et al. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science 1993; 262: 1274-1277.
24. Pourzand C., Rossier G., Reelfs O., Borner C., Tyrrell R. M. The overexpression of Bcl-2 inhibits UVA-mediated apoptosis in rat 6 fibroblasts: Evidence for the involvement of Bcl-2 as an antioxidant. Can Res 1997; 57: 1405-1411.
25. Evan G., Harrington E., McCarthy N. et al. Integrated control of cell proliferation and apoptosis by oncogenes. In: Thomas N. S. B, ed. Apoptosis and Cell Cycle Control in Cancer. Oxford: Bios Scientific, 1996: 109.
26. Bronner M. P., Culin C., Reed J. C., Furth E. E. The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. Am J Pathol 1995; 146: 20-26.
27. Charlotte F., L'Hermine A., Martin N. et al. Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Am J Pathol 1994; 144: 460-465.
28. Zhao M., Zhang N-X., Economou M., Blaha I., Laissue J. A., Zimmerman A. Immunohistochemical detection of bcl-2 protein in liver lesions: bcl-2 protein is expressed in hepatocellular carcinomas but not in liver cell dysplasia. Histopathology 1994; 25: 237-245.
29. Steinmetz K. A., Potter J. D. Vegetables, fruit, and cancer. I. Epidemiology. Cancer Causes Cont 1991; 2: 325-357.